Upgrade to SI Premium - Free Trial

Genmab A/S (GMAB) PT Raised to $50 at H.C. Wainwright

October 7, 2026 6:51 AM
(Updated - October 7, 2026 6:51 AM EDT)

H.C. Wainwright analyst Raghuram Selvaraju raised the price target on Genmab ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change